Quantum BioPharma
- Country
- Ownership
- -
- Employees
- 8
- Market Cap
- -
- Introduction
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants
- Conditions
- Heathy Participants
- Interventions
- Drug: Lucid-21-302Drug: Placebo
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Huge Biopharma Australia Pty Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT06595706
- Locations
- 🇦🇺
Cmax Clinical Research, Adelaide, Maryland, Australia
Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication
- Conditions
- Acute Alcohol Intoxication
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: FSD-F2R6-A-CP
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Quantum Biopharma
- Target Recruit Count
- 30
- Registration Number
- NCT06505239
- Locations
- 🇺🇸
Applied Science and Performance Institute, Tampa, Florida, United States